These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 25438460)

  • 1. Belimumab for the treatment of refractory systemic lupus erythematosus: real-life experience in the first year of use in 18 Italian patients.
    Andreoli L; Reggia R; Pea L; Frassi M; Zanola A; Cartella S; Franceschini F; Tincani A
    Isr Med Assoc J; 2014 Oct; 16(10):651-3. PubMed ID: 25438460
    [No Abstract]   [Full Text] [Related]  

  • 2. Belimumab use, clinical outcomes and glucocorticoid reduction in patients with systemic lupus erythematosus receiving belimumab in clinical practice settings: results from the OBSErve Canada Study.
    Touma Z; Sayani A; Pineau CA; Fortin I; Matsos M; Ecker GA; Chow A; Iczkovitz S
    Rheumatol Int; 2017 Jun; 37(6):865-873. PubMed ID: 28280970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disease control and safety of belimumab plus standard therapy over 7 years in patients with systemic lupus erythematosus.
    Ginzler EM; Wallace DJ; Merrill JT; Furie RA; Stohl W; Chatham WW; Weinstein A; McKay JD; McCune WJ; Zhong ZJ; Freimuth WW; Petri MA;
    J Rheumatol; 2014 Feb; 41(2):300-9. PubMed ID: 24187095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of non-renal non-neurologic persistent lupus activity in real world patients from Argentina.
    Scolnik M; Scaglioni V; Pons-Estel GJ; Soriano ER
    Lupus; 2019 Aug; 28(9):1167-1173. PubMed ID: 31299882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Long-term follow-up of patients with refractory systemic lupus erythematosus during rituximab treatment].
    Tsanian MÉ; Solov'ev SK; Torgashina AV; Aleksandrova EN; Radenska-Lopovok SG; Nikolaeva EV; Khrennikova IaB; Nasonov EL
    Ter Arkh; 2014; 86(5):40-9. PubMed ID: 25026801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Systemic lupus erythematosus with neurologic onset and secondary antiphospholipid syndrome. A Case Study].
    Dima-Cozma C; Pandele GI; Rezuş E; Constantinescu A; Mihailovici MS
    Rev Med Chir Soc Med Nat Iasi; 2005; 109(2):254-8. PubMed ID: 16607781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Belimumab for the treatment of corticosteroid-dependent systemic lupus erythematosus: from clinical trials to real-life experience after 1 year of use in 48 Brazilian patients.
    Scheinberg M; de Melo FF; Bueno AN; Costa CM; de Azevedo Bahr ML; Reis ER
    Clin Rheumatol; 2016 Jul; 35(7):1719-23. PubMed ID: 27106543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized, open-label study to investigate the effect of belimumab on pneumococcal vaccination in patients with active, autoantibody-positive systemic lupus erythematosus.
    Chatham W; Chadha A; Fettiplace J; Kleoudis C; Bass D; Roth D; Gordon D
    Lupus; 2017 Dec; 26(14):1483-1490. PubMed ID: 28467293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of concomitant medication use on belimumab efficacy and safety in patients with systemic lupus erythematosus.
    Schwarting A; Dooley MA; Roth DA; Edwards L; Thompson A; Wilson B
    Lupus; 2016 Dec; 25(14):1587-1596. PubMed ID: 27488472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Systemic lupus erythematosus - Standards in 2015].
    Aringer M; Schneider M
    Dtsch Med Wochenschr; 2014 Sep; 139(37):1813-6. PubMed ID: 25180995
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparison of intravenous and subcutaneous exposure supporting dose selection of subcutaneous belimumab systemic lupus erythematosus Phase 3 program.
    Yapa SW; Roth D; Gordon D; Struemper H
    Lupus; 2016 Nov; 25(13):1448-1455. PubMed ID: 27072354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patient Evaluation of Satisfaction and Outcomes with an Autoinjector for Self-Administration of Subcutaneous Belimumab in Patients with Systemic Lupus Erythematosus.
    Dashiell-Aje E; Harding G; Pascoe K; DeVries J; Berry P; Ramachandran S
    Patient; 2018 Feb; 11(1):119-129. PubMed ID: 28956281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful treatment of refractory lupus nephritis by the sequential use of rituximab and belimumab.
    Simonetta F; Allali D; Roux-Lombard P; Chizzolini C
    Joint Bone Spine; 2017 Mar; 84(2):235-236. PubMed ID: 27238199
    [No Abstract]   [Full Text] [Related]  

  • 14. Belimumab in refractory organizing pneumonia associated with systemic lupus erythematosus: a case report.
    Giménez AR; Pastrana DB; Huaranga MAR; Izquierdo JR; Cabrera B; García AN; Rodríguez CCR
    Lupus; 2019 Apr; 28(4):565-568. PubMed ID: 30862250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alopecia areata in patients with systemic lupus erythematosus treated with belimumab: a plausible association.
    Shamriz O; Yahia SH; Ramot Y; Agmon-Levin N; Tal Y
    Lupus; 2020 Apr; 29(4):426-430. PubMed ID: 31924144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of belimumab treatment on antiphospholipid antibody levels: post-hoc analysis based on two randomised placebo-controlled trials in systemic lupus erythematosus.
    Chatzidionysiou K; Samoli E; Sfikakis PP; Tektonidou MG
    Ann Rheum Dis; 2020 Feb; 79(2):304-307. PubMed ID: 31712248
    [No Abstract]   [Full Text] [Related]  

  • 17. Bilateral optic neuritis in pediatric systemic lupus erythematosus associated with antiphospholipid antibodies and neuromyelitis optica immunoglobulin.
    Wei W; Zerfoss E; Ashker L; Cantore WA
    J Pediatr Ophthalmol Strabismus; 2010 May; 47 Online():e1-4. PubMed ID: 21214161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of a novel autoinjector for subcutaneous self-administration of belimumab in systemic lupus erythematosus
.
    Sheikh SZ; Hammer AE; Fox NL; Groark J; Struemper H; Roth D; Gordon D
    Int J Clin Pharmacol Ther; 2016 Nov; 54(11):914-922. PubMed ID: 27668697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of Belimumab in Children With Systemic Lupus Erythematosus.
    Dimelow R; Ji B; Struemper H
    Clin Pharmacol Drug Dev; 2021 Jun; 10(6):622-633. PubMed ID: 33245847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Initial manifestation by cerebral vasculitis in systemic lupus erythematosus].
    Mrabet D; Meddeb N; Sahli H; Rammeh N; Sellami S
    Tunis Med; 2008 Jun; 86(6):618-9. PubMed ID: 19216467
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.